WST - West Pharmaceutical Services, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5 10.68B
Enterprise Value 3 10.72B
Trailing P/E 47.53
Forward P/E 1 41.84
PEG Ratio (5 yr expected) 1 5.19
Price/Sales (ttm) 6.04
Price/Book (mrq) 7.32
Enterprise Value/Revenue 3 6.07
Enterprise Value/EBITDA 6 28.29

Trading Information

Stock Price History

Beta (3Y Monthly) 1.31
52-Week Change 3 19.11%
S&P500 52-Week Change 3 3.40%
52 Week High 3 152.10
52 Week Low 3 91.75
50-Day Moving Average 3 143.53
200-Day Moving Average 3 123.77

Share Statistics

Avg Vol (3 month) 3 312.87k
Avg Vol (10 day) 3 384.07k
Shares Outstanding 5 73.75M
Float 73.04M
% Held by Insiders 1 0.96%
% Held by Institutions 1 95.22%
Shares Short (Aug 15, 2019) 4 605.08k
Short Ratio (Aug 15, 2019) 4 1.59
Short % of Float (Aug 15, 2019) 4 0.94%
Short % of Shares Outstanding (Aug 15, 2019) 4 0.82%
Shares Short (prior month Jul 15, 2019) 4 481.92k

Dividends & Splits

Forward Annual Dividend Rate 4 0.64
Forward Annual Dividend Yield 4 0.44%
Trailing Annual Dividend Rate 3 0.59
Trailing Annual Dividend Yield 3 0.41%
5 Year Average Dividend Yield 4 0.63
Payout Ratio 4 19.54%
Dividend Date 3 Nov 6, 2019
Ex-Dividend Date 4 Oct 22, 2019
Last Split Factor (new per old) 2 1/2
Last Split Date 3 Sep 27, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq) Jun 30, 2019

Profitability

Profit Margin 12.94%
Operating Margin (ttm) 15.54%

Management Effectiveness

Return on Assets (ttm) 8.59%
Return on Equity (ttm) 16.77%

Income Statement

Revenue (ttm) 1.77B
Revenue Per Share (ttm) 23.90
Quarterly Revenue Growth (yoy) 5.00%
Gross Profit (ttm) 545.4M
EBITDA 378.9M
Net Income Avi to Common (ttm) 228.7M
Diluted EPS (ttm) 3.02
Quarterly Earnings Growth (yoy) 17.80%

Balance Sheet

Total Cash (mrq) 326.7M
Total Cash Per Share (mrq) 4.43
Total Debt (mrq) 272.6M
Total Debt/Equity (mrq) 18.86
Current Ratio (mrq) 3.02
Book Value Per Share (mrq) 19.59

Cash Flow Statement

Operating Cash Flow (ttm) 314.3M
Levered Free Cash Flow (ttm) 115.25M